| Year |
Citation |
Score |
| 2022 |
Jin X, Ng V, Zhao M, Liu L, Higashimoto T, Lee ZH, Chung J, Chen V, Ney G, Kandarpa M, Talpaz M, Li Q. Epigenetic Downregulation of Socs2 Contributes to Mutant N-Ras-Mediated Hematopoietic Dysregulation. Disease Models & Mechanisms. PMID 35352806 DOI: 10.1242/dmm.049088 |
0.649 |
|
| 2021 |
Ney GM, Yang KB, Ng V, Liu L, Zhao M, Kuk W, Alaka L, Sampang L, Ross A, Jones MA, Jin X, McKay LM, Evarts H, Li Q. Oncogenic N-Ras mitigates oxidative stress-induced apoptosis of hematopoietic stem cells. Cancer Research. PMID 33441311 DOI: 10.1158/0008-5472.CAN-20-0118 |
0.689 |
|
| 2020 |
Liu L, Inoki A, Fan K, Mao F, Shi G, Jin X, Zhao M, Ney G, Jones MA, Sun S, Dou Y, Inoki K, Qi L, Li Q. ER associated degradation preserves hematopoietic stem cell quiescence and self-renewal by restricting mTOR activity. Blood. PMID 33150381 DOI: 10.1182/blood.2020007975 |
0.658 |
|
| 2020 |
Ney GM, McKay LM, Koschmann C, Mody R, Li Q. The Emerging Role of Ras Pathway Signaling in Pediatric Cancer. Cancer Research. PMID 32907837 DOI: 10.1158/0008-5472.Can-20-0916 |
0.471 |
|
| 2020 |
Ney GM, Anderson B, Bender J, Kumar-Sinha C, Wu YM, Vats P, Cieslik M, Robinson DR, Li Q, Chinnaiyan AM, Mody R. Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia. Translational Pediatrics. 9: 43-50. PMID 32154134 DOI: 10.21037/Tp.2019.12.03 |
0.427 |
|
| 2019 |
Liu L, Zhao M, Jin X, Ney G, Yang KB, Peng F, Cao J, Iwawaki T, Del Valle J, Chen X, Li Q. Adaptive endoplasmic reticulum stress signalling via IRE1α-XBP1 preserves self-renewal of haematopoietic and pre-leukaemic stem cells. Nature Cell Biology. PMID 30778220 DOI: 10.1038/S41556-019-0285-6 |
0.637 |
|
| 2018 |
Jin X, Qin T, Zhao M, Bailey N, Liu L, Yang K, Ng V, Higashimoto T, Coolon R, Ney G, Figueroa ME, Li Q. Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells. Blood Advances. 2: 1259-1271. PMID 29866713 DOI: 10.1182/Bloodadvances.2018017400 |
0.683 |
|
| 2016 |
Liu L, Zhao M, Yang KB, Jin X, Ney G, Del Valle J, Iwawaki T, Li Q. N-RasG12D-Mediated Dysregulation of IRE1alpha-Xbp1s Signaling Promotes Pre-Leukemic Hematopoietic Stem Cell Expansion Blood. 128: 567-567. DOI: 10.1182/Blood.V128.22.567.567 |
0.665 |
|
| 2016 |
Jin X, Qin T, Bailey NG, Zhao M, Yang KB, Ng V, Liu L, Coolon R, Ney G, Figueroa ME, Li Q. Hyperactive Nras and Dose Reduction of Tet2 Collaborate to Dys-Regulate Hematopoietic Stem Cells and Promote Leukemogenesis Blood. 128: 1204-1204. DOI: 10.1182/Blood.V128.22.1204.1204 |
0.662 |
|
| 2015 |
Palmbos PL, Wang L, Yang H, Wang Y, Leflein J, Ahmet ML, Wilkinson JE, Kumar-Sinha C, Ney G, Tomlins SA, Daignault SD, Kunju LP, Wu XR, Lotan Y, Liebert M, et al. ATDC (TRIM29) Drives Invasive Bladder Cancer Formation. Cancer Research. PMID 26471361 DOI: 10.1158/0008-5472.Can-15-0603 |
0.339 |
|
| 2015 |
Yang H, Palmbos PL, Wang L, Kim EH, Ney GM, Liu C, Prasad J, Misek DE, Yu X, Ljungman M, Simeone DM. ATDC (Ataxia Telangectasia Group D Complementing) Promotes Radioresistance Through an Interaction with the RNF8 Ubiquitin Ligase. The Journal of Biological Chemistry. PMID 26381412 DOI: 10.1074/Jbc.M115.665489 |
0.36 |
|
| 2015 |
Wang L, Yang H, Abel EV, Ney GM, Palmbos PL, Bednar F, Zhang Y, Leflein J, Waghray M, Owens S, Wilkinson JE, Prasad J, Ljungman M, Rhim AD, Pasca di Magliano M, et al. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis. Genes & Development. 29: 171-83. PMID 25593307 DOI: 10.1101/Gad.253591.114 |
0.445 |
|
| 2015 |
Yang KB, Ng V, Ney G, Liu L, Jin X, Li Q. Oncogenic Nras Grants Apoptosis Resistance to Hematopoietic Stem Cells Blood. 126: 2451-2451. DOI: 10.1182/Blood.V126.23.2451.2451 |
0.696 |
|
| 2014 |
Wang L, Yang H, Palmbos PL, Ney G, Detzler TA, Coleman D, Leflein J, Davis M, Zhang M, Tang W, Hicks JK, Helchowski CM, Prasad J, Lawrence TS, Xu L, et al. ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells. Cancer Research. 74: 1778-88. PMID 24469230 DOI: 10.1158/0008-5472.Can-13-2289 |
0.557 |
|
| 2013 |
Palmbos P, Wang L, Yang H, Detzler T, Ney G, Hart J, Daignault-Newton S, Kunju LP, Kumar-Sinha C, Liebert M, Ljungman M, Simeone D. Abstract 313: ATDC drives bladder cancer formation by promoting methylation of the PTEN promoter and inhibition of p53 function. Cancer Research. 73: 313-313. DOI: 10.1158/1538-7445.Am2013-313 |
0.365 |
|
| 2012 |
Palmbos PL, Wang L, Yang H, Detzler T, Ney G, Lotan Y, Wilkerson JE, Kunju P, Ljungman M, Liebert M, Simeone DM. ATDC as a novel oncogene in bladder cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 269. PMID 27968252 DOI: 10.1200/Jco.2012.30.5_Suppl.269 |
0.322 |
|
| 2012 |
Palmbos PL, Wang L, Yang H, Detzler T, Ney G, Lotan Y, Healy PN, Daignault-Newton S, Kunju P, Kumar C, Ljungman M, Liebert M, Simeone DM. Novel oncogenic function of ATDC in bladder cancer. Journal of Clinical Oncology. 30: 4591-4591. DOI: 10.1200/Jco.2012.30.15_Suppl.4591 |
0.361 |
|
| 2012 |
Wang L, Yang H, Bednar F, Zhang Y, Leflein J, Detzler T, Ney GM, Magliano MPd, Simeone DM. Abstract B49: ATDC synergizes with oncogenic Kras to induce invasive pancreatic adeno-carcinoma in transgenic mice. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B49 |
0.386 |
|
| 2012 |
Wang L, Lawrence T, Xu L, Canman C, Ljungman M, Simeone D, Yang H, Palmbos P, Ney G, Detzler TA, Coleman D, Davis M, Hicks K, Helchowski CM. Abstract A93: Radiation-induced phosphorylation of ATDC via ATM/MAPKAP kinase 2 signaling mediates radioresistance of pancreatic cancer cells. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A93 |
0.44 |
|
| 2006 |
Sundberg TB, Ney GM, Subramanian C, Opipari AW, Glick GD. The immunomodulatory benzodiazepine Bz-423 inhibits B-cell proliferation by targeting c-myc protein for rapid and specific degradation. Cancer Research. 66: 1775-82. PMID 16452238 DOI: 10.1158/0008-5472.Can-05-3476 |
0.374 |
|
| Show low-probability matches. |